Quantcast
Last updated on April 17, 2014 at 7:54 EDT

Latest autoimmune diseases Stories

2013-11-08 12:23:16

NARBERTH, Pa., Nov. 8, 2013 /PRNewswire/ -- The GBS/CIDP Foundation International has established the Benson Fellowship to fund Peripheral Neuropathy Fellowships in honor of Robert Benson, a survivor of Guillain-Barre' Syndrome, and his wife Estelle Benson. The Foundation voted to endow over $1,600,000 of its financial resources to initially fund the Fellowship. (Logo: http://photos.prnewswire.com/prnh/20131108/PH13565LOGO ) The purpose of the Benson Fellowship is to encourage...

New findings reported in the journal eLife add evidence that the trillions of microbes in the human body play a major role in regulating health.
2013-11-06 19:01:50

Lee Rannals for redOrbit.com – Your Universe Online New findings reported in the journal eLife add evidence that the trillions of microbes in the human body play a major role in regulating health. Scientists used a sophisticated DNA analysis to compare gut bacteria from fecal samples of patients with rheumatoid arthritis and healthy individuals. The team found that P. copri was more abundant in patients newly diagnosed with rheumatoid arthritis than in healthy individuals or patients...

2013-11-05 08:31:17

NORWALK, Conn., Nov. 5, 2013 /PRNewswire/ -- UBM Medica US announces that Rheumatology Network presents comprehensive coverage of the 2013 annual meeting of the American College of Rheumatology, specialists in inflammatory and auto-immune disorders including rheumatoid arthritis, lupus, and gout. Concluded last week in San Diego, the massive conference included many pioneering insights into these baffling diseases. Rheumatology Network, an independent online community created for these...

2013-11-04 15:29:54

Inflammatory demyelinating pseudotumor usually occurs in the brain and rarely occurs in the spinal cord. On imaging, inflammatory demyelinating pseudotumor appears very similar to intramedullary tumors such as gliomas. It is often misdiagnosed as intramedullary tumor and surgically resected. In view of this, the clinical and magnetic resonance imaging manifestations and the pathological features of 36 cases of inflammatory demyelinating pseudotumor in the spinal cord were retrospectively...

2013-11-04 04:21:59

BREDA, The Netherlands and GHENT, Belgium, November 4, 2013 /PRNewswire/ -- Funds to advance ARGX-113, a novel antibody fragment approach to promote degradation and clearance of disease-causing autoantibodies, towards clinical development arGEN-X, a clinical stage human therapeutic antibody company, has raised EUR 5 million ($6.8 million) as an extension of its series B financing round from the Flemish investment company PMV as a new investor. arGEN-X' series B round,...

2013-10-31 12:27:22

-- Results presented as late breaker at American College of Rheumatology -- LAKE FOREST, Ill., Oct. 31, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, this week shared the results of two open-label extension studies of CT-P13 (infliximab), one in patients with rheumatoid arthritis, the other in patients with ankylosing spondylitis, which were presented at the 2013 American College of Rheumatology (ACR)/Association of...

2013-10-31 08:28:37

Lupus Science & Medicine Will Provide International Focal Point for Clinicians and Researchers Across Multiple Disciplines WASHINGTON, Oct. 31, 2013 /PRNewswire-USNewswire/ -- International knowledge healthcare provider BMJ and the Lupus Foundation of America (LFA) have announced that they have joined forces to publish the first open access journal dedicated to the poorly understood and potentially life threatening disease, lupus. (Logo:...

2013-10-30 08:32:29

The New Oral JAK Inhibitor Xeljanz Has Yet to Carve-Out a Distinct Place in the RA Treatment Algorithm, According to a New Report from BioTrends Research Group EXTON, Pa., Oct. 30, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. rheumatologists are moderately satisfied with the currently available biologic agents as well as Pfizer's Xeljanz for the treatment of...

2013-10-30 08:32:16

Key Drivers of Growth Will Be the Continued Uptake of Benlysta and the Entry of Several Premium-Priced Biologics, According to Findings from Decision Resources BURLINGTON, Mass., Oct. 30, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the systemic lupus erythematosus (SLE) market will grow dramatically over the next decade from approximately $900 million in 2012 to $4 billion in...

2013-10-29 23:28:47

A new report and video from Health News Wires titled Specific Digestive Disorders Linked to Increase in Heart Attacks details how certain digestive disorders increase the risk of heart attack and stroke. Boston, MA (PRWEB) October 29, 2013 A new report and video from Health News Wires titled Specific Digestive Disorders Linked to Increase in Heart Attacks details how certain digestive disorders increase the risk of heart attack and stroke. People suffering from inflammatory bowel disease,...